SIMPLEX TRADING, LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 6 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,182
+6.6%
19,400
-10.6%
0.00%0.0%
Q2 2023$2,046
+553.7%
21,700
+600.0%
0.00%
Q1 2023$313
-89.7%
3,100
-87.8%
0.00%
-100.0%
Q4 2022$3,045
-99.8%
25,500
+44.1%
0.00%
+50.0%
Q3 2022$1,879,000
+138.1%
17,700
+118.5%
0.00%
+100.0%
Q2 2022$789,000
-60.3%
8,100
-61.8%
0.00%
-50.0%
Q1 2022$1,987,000
+188.4%
21,200
+161.7%
0.00%
+100.0%
Q4 2021$689,000
-80.9%
8,100
-78.1%
0.00%
-66.7%
Q3 2021$3,606,000
+0.2%
37,0000.0%0.00%0.0%
Q2 2021$3,600,000
+33.2%
37,000
+13209.4%
0.00%
-40.0%
Q1 2021$2,703,000
+20.0%
278
+18.3%
0.01%
+66.7%
Q4 2020$2,252,000
+10.5%
235
+10.8%
0.00%0.0%
Q3 2020$2,038,000
-13.4%
212
+9.8%
0.00%
-25.0%
Q2 2020$2,354,000
+5.8%
193
-24.9%
0.00%0.0%
Q1 2020$2,224,000
+137.9%
257
+195.4%
0.00%
+100.0%
Q4 2019$935,000
-68.0%
87
-73.1%
0.00%
-75.0%
Q3 2019$2,919,000
-15.2%
324
-20.6%
0.01%
-11.1%
Q2 2019$3,444,000
+6.2%
408
+10.9%
0.01%0.0%
Q1 2019$3,242,000
-31.5%
368
-44.5%
0.01%
-35.7%
Q4 2018$4,734,000
+54.7%
663
+166.3%
0.01%
+40.0%
Q3 2018$3,061,000
+109.2%
249
+67.1%
0.01%
+66.7%
Q2 2018$1,463,000
+2338.3%
149
-51.5%
0.01%
+100.0%
Q1 2018$60,000
-55.2%
307
+189.6%
0.00%
-50.0%
Q4 2017$134,000
+6600.0%
106
+2020.0%
0.01%
Q3 2017$2,000
-89.5%
5
-97.4%
0.00%
-100.0%
Q2 2017$19,000
-68.9%
193
-14.6%
0.00%
-66.7%
Q1 2017$61,000
+258.8%
226
+232.4%
0.00%
+200.0%
Q4 2016$17,000
-75.4%
68
-76.1%
0.00%
-80.0%
Q3 2016$69,000
-58.2%
284
-55.2%
0.01%
-54.5%
Q2 2016$165,000
+73.7%
634
+183.0%
0.01%
+37.5%
Q1 2016$95,000
-52.3%
224
+19.1%
0.01%
-50.0%
Q4 2015$199,000
+116.3%
188
-17.9%
0.02%
+128.6%
Q3 2015$92,000
-29.8%
229
+18.7%
0.01%
-36.4%
Q2 2015$131,000
-50.2%
193
+53.2%
0.01%
-64.5%
Q1 2015$263,000
+86.5%
126
-55.8%
0.03%
+82.4%
Q4 2014$141,0002850.02%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 25$240,0000.01%
GROUP ONE TRADING, L.P. 31,300$3,000,0000.01%
SIMPLEX TRADING, LLC 235$2,252,0000.00%
Interchange Capital Partners, LLC 2$1,0000.00%
JPMORGAN CHASE & CO 41,800$4,007,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders